{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"}],"units":"Participants"}],"groups":[{"description":"Patients receiving Fludarabine, Busulfan, cyclophosphamide and post-transplant cyclophosphamide for a haploidentical donor transplant","id":"OG000","title":"Haploidentical Transplant"}],"paramType":"NUMBER","populationDescription":"2 patients died before Day 100 and therefore are eligible to be evaluated for non-relapse mortality","reportingStatus":"POSTED","timeFrame":"Day 100","title":"Non-relapse Mortality at Day 100 After Peripheral Blood Stem Cell Transplantation (PBSCT)","type":"SECONDARY","unitOfMeasure":"participants"}